BIOMAT Database Logo BIOMAT Database Logo

[Clinical effect of a beta receptor blockader, oxprenolol, in hypertension--its relationship with renin-aldosterone activities]. 1974

H Kunida, and S Hatake, and M Okamoto

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010096 Oxprenolol A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety. Coretal,Koretal,Oxprenolol Hydrochloride,Slow Trasicor,Tevacor,Trasicor,Hydrochloride, Oxprenolol,Trasicor, Slow
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Kunida, and S Hatake, and M Okamoto
[Antihypertensive effect of carteolol, a beta-receptor blockader, in essential hypertension and its action on the renin-aldosterone system].
August 1977, Horumon to rinsho. Clinical endocrinology,
H Kunida, and S Hatake, and M Okamoto
[Therapy of excited psychoses using a beta receptor blockader (oxprenolol) in high dosage].
September 1972, Der Nervenarzt,
H Kunida, and S Hatake, and M Okamoto
[Clinical test of a new beta-receptor blockader in labile hypertension].
January 1971, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H Kunida, and S Hatake, and M Okamoto
[Comparative trial of combined oxprenolol-chlorthalidone and a beta-blockader and diuretic separately in primary arterial hypertension].
October 1979, Arquivos brasileiros de cardiologia,
H Kunida, and S Hatake, and M Okamoto
[Effect of chronic beta-receptor blockade in blood pressure and renin and aldosterone secretion in essential hypertension].
January 1975, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H Kunida, and S Hatake, and M Okamoto
[Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
January 1972, Masui. The Japanese journal of anesthesiology,
H Kunida, and S Hatake, and M Okamoto
[Clinical pharmacological effect of Soviet-made adrenergic beta receptor blockader Benzoral].
August 1974, Kardiologiia,
H Kunida, and S Hatake, and M Okamoto
[Plasma aldosterone and renin activities in various types of hypertension].
January 1976, Horumon to rinsho. Clinical endocrinology,
H Kunida, and S Hatake, and M Okamoto
[Adrenergic beta receptor blockader celiprolol in the treatment of patients with arterial hypertension].
February 1990, Klinicheskaia meditsina,
H Kunida, and S Hatake, and M Okamoto
[Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
July 1970, Zeitschrift fur arztliche Fortbildung,
Copied contents to your clipboard!